All In MedTech

Device Trial Radar · NCT06324682

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

Evaluation of conTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

Last checked: Nov 19, 2026Latest source record: Mar 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

8,400

Planned (sponsor's estimate)

Start

Jan 1, 2023

Primary completion

Dec 31, 2033

Study completion Dec 31, 2034

Sponsor

Lead sponsor
University Hospital of FerraraAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 22, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational study is to evaluate the clinical characteristics of patients undergoing permanent cardiac pacing and to compare procedural efficacy and safety of different implantation approaches in the clinical practice of the participating centres. The contribution of non-fluoroscopic anatomical and electrophysiological reconstruction systems to device implantation procedures will also be evaluated. Participants \[patients over 18 years old with an indication to receive a definitive pacemaker/intracardiac defibrillator implant\] will receive a permanent cardiac pacing implant as requested according to European Society of Cardiology (ESC) guidelines; the investigators will evaluate procedural efficacy and safety of different implantation approaches.

Conditions

  • Arrhythmias, Cardiac
  • Atrioventricular Block
  • Reduced Systolic Function
  • Atrial Fibrillation
  • Bradyarrhythmia
  • Ventricular Tachycardia
  • Ventricular Dysfunction
  • Ventricular Fibrillation
  • Ventricular Arrythmia
  • Atrioventricular Nodal Disease
  • Atrioventricular Conduction Defects
  • Atrioventricular Block Complete
  • Atrioventricular Block Incomplete
  • Atrioventricular Junctional Rhythm
  • Bundle-Branch Block
  • Left Bundle-Branch Block
  • Heart Failure, Systolic
  • Block;Atrioventricular
  • Block; Arrhythmic
  • Block; Mobitz
  • Block, Heart
  • Block, Fascicular
  • Block Branch Bundle Left
  • Heart Failure,Congestive
  • Heart Arrhythmia

Interventions

  • Cardiac pacing - Conventional RV pacingDevice

    Implantation of devices for cardiac pacing/defibrillation

  • Cardiac pacing - Conduction System PacingDevice

    Implantation of devices for cardiac pacing/defibrillation

  • Cardiac pacing - Cardiac resynchronization therapy (pacing - CRTP - or defibrillation - CRTD)Device

    Implantation of devices for cardiac pacing/defibrillation

  • Cardiac pacing - Epicardial pacingDevice

    Implantation of devices for cardiac pacing/defibrillation

  • Cardiac pacing - Leadless pacingDevice

    Implantation of devices for cardiac pacing/defibrillation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 30 days efficacyTime frame: 30 days
  2. Rate of hospitalizations for heart failure at 12 monthsTime frame: 12 months
  3. All cause death at 12 monthsTime frame: 12 months

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • Ospedale San Donato

    Arezzo, Italy · Recruiting

  • Azienda Ospedaliero-Universitaria S.Orsola-Malpighi Bologna

    Bologna, Italy · Recruiting

  • spedale Maggiore di Bologna

    Bologna, Italy · Recruiting

28 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.